PS Ratio
N/A
6 min ago
Summary
- CRSP price to sales ratio is not available.
Performance
CRSP PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CRSP PS Ratio Trends
PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | - | +3.1% | +3.1% | - |
1 m1 month | - | +4.2% | +4.2% | - |
3 m3 months | - | -19.1% | -19.1% | - |
6 m6 months | - | -12.2% | -12.0% | - |
ytdytd | - | +4.9% | +4.9% | - |
1 y1 year | - | -46.1% | -42.5% | - |
5 y5 years | - | -28.6% | +0.2% | - |
CRSP PS Ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | ||||
3 m | 3-month | ||||
6 m | 6-month | ||||
1 y | 1-year | 20.31 | 15.10 | ||
3 y | 3-year | 10.08 K | 3.67 | ||
5 y | 5-year | 28.59 K | 3.67 | ||
alltime | all time | 28.59 K | 3.67 |
CRISPR Therapeutics AG PS Ratio History
Date | Value |
---|---|
2023 | 13.58(-99.8%) |
2022 | 7523.51(>+9900.0%) |
2021 | 6.39(-100.0%) |
2020 | 20.84 K(>+9900.0%) |
Date | Value |
---|---|
2019 | 12.78(-97.3%) |
2018 | 474.21(+1939.6%) |
2017 | 23.25(-85.1%) |
2016 | 155.83 |
FAQ
- What is the all time high PS ratio for CRISPR Therapeutics AG?
What is the all time high PS ratio for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high price to sales ratio is 28.59 K